Molecular Therapy - Methods & Clinical Development

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Volume 94, Issue 2, Pages (March 2014)
Molecular Therapy - Oncolytics
HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells  Sugiko Watanabe, Yasuaki Ueda, Shin-ichi Akaboshi,
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells  Mouldy Sioud,
Volume 15, Issue 6, Pages (June 2007)
Léa L Lesueur, Lluis M Mir, Franck M André 
Volume 144, Issue 3, Pages e1 (March 2013)
MicroRNA-31 Promotes Skin Wound Healing by Enhancing Keratinocyte Proliferation and Migration  Dongqing Li, X.I. Li, Aoxue Wang, Florian Meisgen, Andor.
Molecular Therapy - Methods & Clinical Development
Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy  Yuka Igarashi, Toru Uchiyama, Tomoko Minegishi, Sirirat.
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets.
Volume 4, Issue 1, Pages (July 2001)
Molecular Therapy - Nucleic Acids
Volume 18, Issue 5, Pages (May 2010)
Volume 15, Issue 1, Pages (January 2007)
Pulmonary Fibroblasts Induce Epithelial Mesenchymal Transition and Some Characteristics of Stem Cells in Non-Small Cell Lung Cancer  Yasushi Shintani,
Molecular Therapy - Methods & Clinical Development
Expression of Indoleamine 2,3-Dioxygenase in Dermal Fibroblasts Functions as a Local Immunosuppressive Factor  Yunyuan Li, Edward E. Tredget, Ruhangiz.
Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells  Mouldy Sioud,
Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D  George W. Agak, Min Qin, Jennifer Nobe,
Molecular Therapy - Oncolytics
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Transduction of Human Embryonic Stem Cells by Foamy Virus Vectors
Molecular Therapy - Methods & Clinical Development
Volume 24, Issue 8, Pages (August 2018)
Zihua Zeng, Ching-Hsuan Tung, Youli Zu 
Molecular Therapy - Methods & Clinical Development
Volume 144, Issue 3, Pages e1 (March 2013)
Neonatal Gene Therapy for Hemophilia B by a Novel Adenovirus Vector Showing Reduced Leaky Expression of Viral Genes  Shunsuke Iizuka, Fuminori Sakurai,
Volume 22, Issue 2, Pages (February 2014)
Léa L Lesueur, Lluis M Mir, Franck M André 
Volume 20, Issue 1, Pages (January 2012)
Molecular Therapy - Oncolytics
Autocrine IL-21 Stimulation Is Involved in the Maintenance of Constitutive STAT3 Activation in Sézary Syndrome  Leslie van der Fits, Jacoba J. Out-Luiting,
Particle Tracking Analysis for the Intracellular Trafficking of Nanoparticles Modified with African Swine Fever Virus Protein p54-derived Peptide  Hidetaka.
Molecular Therapy - Oncolytics
Volume 24, Issue 9, Pages (September 2016)
Molecular Therapy - Nucleic Acids
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Volume 9, Issue 5, Pages (November 2017)
Molecular Therapy - Oncolytics
Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury  Kosuke Fujita, Koji M. Nishiguchi, Yukihiro.
Volume 23, Issue 1, Pages (January 2015)
by Wanqiu Hou, James S. Gibbs, Xiuju Lu, Christopher B
Thomas S. Griffith, Elizabeth L. Broghammer  Molecular Therapy 
TGFβ Inhibits CD1d Expression on Dendritic Cells
Volume 19, Issue 4, Pages (April 2011)
IL-12 affects Dermatophagoides farinae–induced IL-4 production by T cells from pediatric patients with mite-sensitive asthma  Takeshi Noma, MD, PhD, Izumi.
Md Nasimuzzaman, Danielle Lynn, Johannes CM van der Loo, Punam Malik 
Molecular Therapy - Nucleic Acids
Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-κB  Mitsuhiro Machitani, Fuminori Sakurai, Keisaku Wakabayashi,
A.K.I. Kuroki, Masayuki Iyoda, Takanori Shibata, Tetsuzo Sugisaki 
In Vivo Tracking of Mesechymal Stem Cells Using Fluorescent Nanoparticles in an Osteochondral Repair Model  Jong Min Lee, Byung-Soo Kim, Haeshin Lee,
Decreased expression of cell cycle– and apoptosis-related genes in Aml1-excised leukemia cell. Decreased expression of cell cycle– and apoptosis-related.
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Volume 6, Issue 3, Pages (September 2002)
Valerie Künzi, Patrick A
Volume 23, Issue 3, Pages (March 2015)
Single-Shot, Multicycle Suicide Gene Therapy by Replication-Competent Retrovirus Vectors Achieves Long-Term Survival Benefit in Experimental Glioma  Chien-Kuo.
Volume 2, Issue 4, Pages (October 2000)
Volume 20, Issue 11, Pages (November 2012)
High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors  Yani Hu,
Volume 20, Issue 4, Pages (April 2012)
Molecular Therapy - Methods & Clinical Development
Volume 12, Issue 5, Pages (November 2005)
Presentation transcript:

Molecular Therapy - Methods & Clinical Development Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirus  Fuminori Sakurai, Nobuhiro Narii, Kyoko Tomita, Shinsaku Togo, Kazuhisa Takahashi, Mitsuhiro Machitani, Masashi Tachibana, Masaaki Ouchi, Nobuyoshi Katagiri, Yasuo Urata, Toshiyoshi Fujiwara, Hiroyuki Mizuguchi  Molecular Therapy - Methods & Clinical Development  Volume 3, (January 2016) DOI: 10.1038/mtm.2016.1 Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Schematic diagram of conditionally replicating Ads used in this study. (a) rAd-GFP, (b) rAdF35-GFP, and (c) rAdF35-142T-GFP. rAdF35-GFP was developed by replacing the fiber protein of rAd-GFP with Ad35 fiber protein. rAdF35-142T-GFP was developed by inserting miR-142-3p–targeted sequences into the 3′-UTR of both the E1 gene and GFP gene of rAdF35-GFP. CMV, cytomegalovirus; GFP, green fluorescence protein; hTERT, human telomerase reverse transcriptase; IRES, internal ribosomal entry site; ITR, internal terminal repeat; pA, bovine growth hormone polyadenylation signal; UTR, untranslated region. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.1) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Expression levels of coxsackievirus–adenovirus receptor (CAR), CD46, miR-142-3p, and human telomerase reverse transcriptase (hTERT) in the human cancer cell lines. (a) Surface expression levels of CAR and CD46 were assessed by flow cytometry. Open histograms represent isotype control staining. Filled histograms represent specific staining with anti-CAR antibody or anti-CD46 antibody. The data shown are representative of multiple measurements. (b) Expression levels of miR-142-3p were determined by real-time RT-PCR. The ratios of miR-142-3p to RNU6B levels were determined. The ratio of K562 cells was normalized to 1. (c) mRNA levels of hTERT were determined by real-time RT-PCR. The ratios of hTERT to GAPDH levels were determined. The ratio of H1299 cells was normalized to 1. Data are expressed as the mean ± SD (n = 3). ND, not detected. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.1) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Green fluorescence protein (GFP) expression levels in the tumor cell lines following infection with the conditionally replicating Ads. (a) The cell suspensions were incubated with the conditionally replicating Ads at MOIs of 1 and 10. Following a 24-hour incubation, the GFP expression levels were determined by flow cytometry. Data are expressed as the mean ± SD (n = 3). *P < 0.001 in comparison with rAd-GFP. #P < 0.001 in comparison with rAdF35-GFP by one-way analysis of variance followed by Shapiro–Wilk's analysis. Time-lapse images of (b) coxsackievirus–adenovirus receptor (CAR)-positive and (c) CAR-negative tumor cells following infection with the conditionally replicating Ads. (b) H1299 cells and (c) T24 cells were infected at an MOI of 10. Selected images taken at the indicated time points show cell morphology by phase-contrast microscopy (right panels) and GFP expression under fluorescence microscopy (left panels). Bar = 100 µm. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.1) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Green fluorescence protein (GFP) expression following infection with the conditionally replicating Ads in the tumor cells undergoing TGF-β–induced epithelial–mesenchymal transition (EMT). (a) Cell morphology images of PANC-1 cells cultured in the presence of transforming growth factor (TGF)-β for 6 days were taken using a phase-contrast microscope. The images shown are representative of multiple experiments. Bar = 75 µm. (b) mRNA levels of EMT marker genes in PANC-1 cells undergoing EMT. The ratios of EMT marker genes to GAPDH were determined. The ratios in PANC-1 cells without TGF-β treatment were normalized to 1. Data are expressed as the mean ± SD (n = 3). (c) Surface expression levels of coxsackievirus–adenovirus receptor (CAR) and CD46 on PANC-1 cells undergoing EMT. The data shown are representative of multiple experiments. (d) GFP expression levels in PANC-1 cells undergoing EMT following infection with the conditionally replicating Ads. PANC-1 cells were infected with the conditionally replicating Ads at MOIs of 1 and 10. GFP expression levels were determined by flow cytometry 24 hours after infection. The data are expressed as the mean ± SD (n = 3). Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.1) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Green fluorescence protein (GFP) expression levels in cells of the human myelogenous leukemia cell line K562 following infection with the conditionally replicating Ad derivatives containing different copy numbers of miR-142-3p–targeted sequences (see Supplementary Table S1). K562 cells were infected with the Ads at the indicated MOIs for 24 hours. GFP expression levels were determined by flow cytometry. Data are expressed as the mean ± SD (n = 3). Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.1) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 6 Green fluorescence protein (GFP) expression in peripheral blood mononuclear cells (PBMCs) from healthy donors following infection with the conditionally replicating Ads. (a) Flow cytometric analysis of GFP expression in PBMCs following infection with the conditionally replicating Ads. PBMCs were infected with the Ads at MOIs of 0.1, 1, and 10 for 24 hours. Data are expressed as the mean ± SD (n = 3). (b) Detection of GFP-positive PBMCs by fluorescence microscopy following infection with the Ads. PBMCs from healthy donors were infected with the indicated amounts of Ads for 24 hours. Numbers of GFP-positive cells were counted by fluorescence microscopy. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.1) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 7 Detection of human cancer cells spiked into peripheral blood mononuclear cells (PBMCs) by the conditionally replicating Ads. H1299 and T24 cells stably expressing red fluorescent protein (RFP) were spiked into PBMCs. The cells were then infected with the Ads for 24 hours. Fluorescence images of (a) H1299 and (b) T24 cells following infection with the Ads. RFP-expressing H1299 and T24 cells (1 × 105 cells) were spiked into 5 × 106 PBMCs. The cells suspended in 1 ml of RPMI1640 medium were incubated with 2 × 107 IFU of the Ads for 24 hours. The expression of green fluorescence protein (GFP) and RFP was observed under a fluorescence microscope. White arrowheads indicate uninfected tumor cells. The images shown are representative of multiple experiments. Bar = 50 µm. (c) Efficiencies of GFP labeling of human cancer cells spiked into PBMCs. RFP-expressing H1299 and T24 cells were spiked into 2 × 106 PBMCs. The cells suspended in 1 ml of RPMI1640 medium were infected with 2 × 107 IFU of the Ads for 24 hours. Measurement of GFP and RFP expression in the cells was carried out by flow cytometry. Data are shown as the mean ± SD (n = 3). Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.1) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions